Deutsche Bank Starts Hutchison China MediTech Ltd. (HCM) at Buy
- Wall Street slips on tech losses, tax uncertainty weighs
- Invesco (IVZ) Reportedly in Talks to Merge With State Street's (STT) Asset Management Business, Citi Sees More Cons than Pros
- Jefferies Raises Price Targets on Alphabet (GOOGL) and Facebook (FB) as They Are Still Inexpensive Relative to Growth, Reiterates Snap (SNAP) as a Best Growth Idea
- Tesla (TSLA) Could Deliver 900K EV Units This Year and 1.3M in 2022 - Wedbush
- Dollar hits three-week high, boosted by recent upbeat data, Fed taper view
Deutsche Bank analyst Rajan Sharma initiates coverage on Hutchison China MediTech Ltd. (NASDAQ: HCM) with a Buy rating and a price target of $40.00.
Shares of Hutchison China MediTech Ltd. closed at $32.70 yesterday.
You May Also Be Interested In
- UPDATE: BofA Securities Starts Rockley Photonics Holdings Ltd (RKLY) at Buy, Sees 56% Upside
- UPDATE: RBC Capital Starts National Retail Properties (NNN) at Sector Perform
- UPDATE: RBC Capital Starts Spirit Realty Capital (SRC) at Sector Perform
Create E-mail Alert Related CategoriesHot New Coverage, New Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!